RT @IMFsupport@twitter.com
Always good to see trials with LESS/NO DEX #569 Dex Sparing-Regimen with Daratumumab and Lenalidomide in Frail Patients with NDMM: Efficacy and Safety Analysis of the Phase 3 IFM2017-03 Trial #ASH22 #IMFASH22 #myeloma @IMFmyeloma@twitter.com
🐦🔗: https://twitter.com/IMFsupport/status/1602019034786037761
RT @IMFsupport@twitter.com
Great #ASH22 Twitter engagement! Thanks to #IMFASH22 team member @IMFnurseMyeloma@twitter.com ! Tweets with NP #myeloma content! @IMFmyeloma@twitter.com
🐦🔗: https://twitter.com/IMFsupport/status/1601917303721005058
RT @IMFsupport@twitter.com
This study provides an evidence based approach to selecting persons with MGUS in whom BM sampling may be deferred #iStopMM @sykristinsson@twitter.com @IMFmyeloma@twitter.com #ASH22 #IMFASH22 #myeloma #smm https://twitter.com/daw6jessie/status/1601615848266817542
🐦🔗: https://twitter.com/IMFsupport/status/1601675823391551488
#istopmm #ash22 #imfash22 #myeloma #smm
RT @IMFnurseMyeloma@twitter.com
Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy
#ASH22 @IMFMyeloma@twitter.com #IMFASH22 #mmsm
🐦🔗: https://twitter.com/IMFnurseMyeloma/status/1601675598115799040
RT @JackMAiello@twitter.com
Dr Martin @TomBmt133@twitter.com looks at pre-CAR-T treatments when CAR-T isn't available for several months and post-CAR-T following relapse. #ASH22 #IMFSpport #IMFASH22
🐦🔗: https://twitter.com/JackMAiello/status/1601299915958759424
RT @MidAtlanticMSG@twitter.com
So excited to listen to some of the best of the best discuss the evolving treatment landscape for Myeloma patients at the IMF Satellite Symposium at #ASH22. @BrianDurieMD@twitter.com, @myelomaMD@twitter.com @TomBmt122@twitter.com @VincentRK@twitter.com , Dr. Moreau, and Dr. San-Miguel. #IMFASH22 #myeloma #mmsm
🐦🔗: https://twitter.com/MidAtlanticMSG/status/1601265194633924613
#ash22 #imfash22 #myeloma #mmsm
RT @Daw6Jessie@twitter.com
Gearing up for #ASH22, looking forward to many scientific presentations, and also this educational program: #IMFASH22 @IMFmyeloma@twitter.com #mmsm
🐦🔗: https://twitter.com/Daw6Jessie/status/1600630491115552768